Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity  Sandra Garcia, BS, Ajit Bisen, MD,

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection.
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
SC17.02 Lung Cancer in China: Challenges and Perspectives
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Anna E. Barón, PhD, Severine Kako, BS, William J
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Neel R. Sodha, MD, Frank W. Sellke, MD 
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer  Suzanne Jenkins, DPhil, James C-H.
Trends in Subpopulations at High Risk for Lung Cancer
Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review.
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Stefano Occhipinti, PhD, Jeff Dunn, PhD, Dianne L
A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib  Parneet K. Cheema, MD, MBiotech, FRCPC  Journal.
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer  Sarita Dubey, MD, Patricia Stephenson, ScD, Donna E. Levy,
Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004.
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature  Caicun Zhou, MD, PhD, Luan Di Yao, MD 
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):
Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E
Maria Q. Baggstrom, MD, Saiama N. Waqar, MD, Ananth K
Support Your Specialty
Pembrolizumab-Induced Encephalopathy: A Review of Neurological Toxicities with Immune Checkpoint Inhibitors  Sophie Feng, M.B.B.S., Jermaine Coward, PhD,
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Onkar V. Khullar, MD, Yuan Liu, PhD, Theresa Gillespie, PhD, Kristin A
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
A first start for lung transplantation?
A Translational View of the Molecular Pathogenesis of Lung Cancer
An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers  Jules L. Derks, MD  Journal of.
A Primer on Health Economic Evaluations in Thoracic Oncology
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
The Number of Pulmonary Metastases: Influence on Practice and Outcome
A Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib (BAY 43– 9006) in Previously Treated Non–Small-Cell Lung Cancer Patients: Eastern.
Nivolumab-Induced Granulomatous Inflammation of the Pleura
Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?  Chenyang Dai, MD, Yijiu Ren, MD, Dong Xie, MD, PhD,
Pulmonary Metastasectomy in Breast Cancer
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Genetic Changes in Squamous Cell Lung Cancer: A Review
European Lung Cancer Conference (ELCC) 2016 Organisation
OA Video-Assisted Thoracoscopic Surgery vs
MA02.10 The First Year of Implementing a Lung Cancer Screening Program in an Urban Safety-Net Health System  H. Hamann, S. Lee, T. Browning, C. Chavez,
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
David Garfield, MD  Journal of Thoracic Oncology 
Who should decide margin length in pulmonary excision of lung cancer?
Induction Therapy For Locally Advanced Thymoma
Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding.
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
A Review of First-Line Treatment for Small-cell Lung Cancer
Robert Comis, MD, The Passing of a “Lung Man”
Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues”  Boris Sepesi,
Presentation transcript:

Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity  Sandra Garcia, BS, Ajit Bisen, MD, Jingsheng Yan, PhD, Xian-Jin Xie, PhD, Suresh Ramalingam, MD, Joan H. Schiller, MD, David H. Johnson, MD, David E. Gerber, MD  Journal of Thoracic Oncology  Volume 12, Issue 10, Pages 1489-1495 (October 2017) DOI: 10.1016/j.jtho.2017.07.020 Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Median number of eligibility criteria over time. Journal of Thoracic Oncology 2017 12, 1489-1495DOI: (10.1016/j.jtho.2017.07.020) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Mean number of eligibility criteria by category over time. CV, cardiovascular; Heme, hematologic; Pulm, pulmonary; GI, gastrointestinal; Neuro, neurologic; Inflamm, inflammatory; Endo, endocrine; Meds, medications; Admin, administrative. Journal of Thoracic Oncology 2017 12, 1489-1495DOI: (10.1016/j.jtho.2017.07.020) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions